Antipsychotic-Induced Dyslipidemia Treated with Omega 3 Fatty Acid Supplement in an 11-Year-Old Psychotic Child: A 1-Year Follow-up

Abstract

Journal of Child and Adolescent PsychopharmacologyVol. 23, No. 2 Letters to the EditorAntipsychotic-Induced Dyslipidemia Treated with Omega 3 Fatty Acid Supplement in an 11-Year-Old Psychotic Child: A 1-Year Follow-upSimone Pisano, Antonella Gritti, Gennaro Catone, and Antonio PascottoSimone PisanoDepartments of Psychiatry, Child Neuropsychiatry, Audiophonology, and Dermatology, Second University of Naples, Naples, Italy.Search for more papers by this author, Antonella GrittiDepartment of Education Sciences, University Suor Orsola Benincasa, Naples, Italy.Search for more papers by this author, Gennaro CatoneDepartments of Psychiatry, Child Neuropsychiatry, Audiophonology, and Dermatology, Second University of Naples, Naples, Italy.Search for more papers by this author, and Antonio PascottoDepartments of Psychiatry, Child Neuropsychiatry, Audiophonology, and Dermatology, Second University of Naples, Naples, Italy.Search for more papers by this authorPublished Online:19 Mar 2013https://doi.org/10.1089/cap.2012.0060AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited ByPutative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical ReviewCurrent Neuropharmacology, Vol. 17, No. 4Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting Marco Pozzi, Simone Pisano, Giuseppe Marano, Carla Carnovale, Carmela Bravaccio, Concetta Rafaniello, Annalisa Capuano, Francesco Rossi, Renata Rizzo, Renato Bernardini, Maria Nobile, Massimo Molteni, Emilio Clementi, Elia Biganzoli, and Sonia Radice7 March 2019 | Journal of Child and Adolescent Psychopharmacology, Vol. 29, No. 2Differences in Metabolic Factors Between Antipsychotic-Induced Weight Gain and Non-pharmacological Obesity in Youths12 February 2018 | Clinical Drug Investigation, Vol. 38, No. 5Conduct disorders and psychopathy in children and adolescents: aetiology, clinical presentation and treatment strategies of callous-unemotional traits20 September 2017 | Italian Journal of Pediatrics, Vol. 43, No. 1Different Immune Signature in Youths Experiencing Antipsychotic-Induced Weight Gain Compared to Untreated Obese Patients Simone Pisano, Gennaro Catone, Giangennaro Coppola, Marco Carotenuto, Raffaella Iuliano, Claudia Tiano, Anna Rita Montesanto, Vittoria D'Esposito, Emanuele Miraglia del Giudice, Pietro Formisano, and Carmela Bravaccio1 November 2017 | Journal of Child and Adolescent Psychopharmacology, Vol. 27, No. 9Polyunsaturated fatty acids and recurrent mood disorders: Phenomenology, mechanisms, and clinical applicationProgress in Lipid ResearchUpdate on the safety of second generation antipsychotics in youths: a call for collaboration among paediatricians and child psychiatrists21 May 2016 | Italian Journal of Pediatrics, Vol. 42, No. 1Diffusion Imaging of White Matter in Schizophrenia: Progress and Future DirectionsBiological Psychiatry: Cognitive Neuroscience and Neuroimaging, Vol. 1, No. 3Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods2 May 2015 | BMC Psychiatry, Vol. 15, No. 1Risperidone11 May 2013 | Reactions Weekly, Vol. 1451, No. 1 Volume 23Issue 2Mar 2013 InformationCopyright 2013, Mary Ann Liebert, Inc.To cite this article:Simone Pisano, Antonella Gritti, Gennaro Catone, and Antonio Pascotto.Antipsychotic-Induced Dyslipidemia Treated with Omega 3 Fatty Acid Supplement in an 11-Year-Old Psychotic Child: A 1-Year Follow-up.Journal of Child and Adolescent Psychopharmacology.Mar 2013.139-141.http://doi.org/10.1089/cap.2012.0060Published in Volume: 23 Issue 2: March 19, 2013Online Ahead of Print:March 12, 2013PDF download